Jump Financial’s Collegium Pharmaceutical COLL Stock Holding History

Jump Financial’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55M	Buy	42,773 +31,173	+269%	+$1.07M	0.01%	994
2026 Q1	$384K	Sell	11,600 -48,901	-81%	-$2.07M	0.01%	1372
2025 Q4	$2.8M	Sell	60,501 -18,035	-23%	-$755K	0.03%	556
2025 Q3	$2.75M	Buy	+78,536	New	+$2.73M	0.03%	616
2025 Q2	–	Sell	-21,600	Closed	-$645K	–	1859
2025 Q1	$645K	Buy	+21,600	New	+$660K	0.01%	984
2024 Q3	–	Sell	-44,776	Closed	-$1.44M	–	1704
2024 Q2	$1.44M	Sell	44,776 -21,064	-32%	-$730K	0.03%	683
2024 Q1	$2.56M	Buy	65,840 +27,540	+72%	+$964K	0.07%	349
2023 Q4	$1.18M	Buy	+38,300	New	+$959K	0.04%	626
2023 Q3	–	Sell	-43,596	Closed	-$937K	–	1901
2023 Q2	$937K	Sell	43,596 -11,405	-21%	-$259K	0.03%	711
2023 Q1	$1.32M	Buy	+55,001	New	+$1.46M	0.05%	500
2021 Q2	–	Sell	-14,852	Closed	-$352K	–	1128
2021 Q1	$352K	Buy	+14,852	New	+$353K	0.03%	547

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Jump Financial's COLL Position: Q2 2026 in Review

Jump Financial increased its Collegium Pharmaceutical (COLL) stake by 269% in Q2 2026, buying an estimated $1.07M and bringing the position to 42,773 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #994.

Jump Financial first reported a position in COLL in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.8M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Jump Financial held 42,773 shares of Collegium Pharmaceutical worth $1.55M as of Q2 2026.
Jump Financial bought 31,173 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.07M.
Collegium Pharmaceutical made up 0.01% of Jump Financial's portfolio in Q2 2026, its #994 holding.
Jump Financial first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 11 quarters since.
Jump Financial's Collegium Pharmaceutical position peaked at $2.8M in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.